Dianthus Therapeutics DNTH
NASDAQ DNTH
$88.21 -0.11 (-0.12%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dianthus Therapeutics (DNTH) Return on Capital Employed [ROCE] (2018 - 2025)

Updated

Dianthus Therapeutics (DNTH) posted Return on Capital Employed [ROCE] of -32.79% for Q3 2025, down 8.82 percentage points from -23.97% a year earlier but up 8.16 percentage points from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Return on Capital Employed [ROCE] (2018 - 2025) Analysis & Trends

For FY2024, Dianthus Therapeutics' Return on Capital Employed [ROCE] came in at -39.44%, up 0.16 percentage points from FY2023.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +17.66 percentage points (FY2019 to FY2024).
  • In prior years, Dianthus Therapeutics' Return on Capital Employed [ROCE] was -39.61% in FY2023 (-16.45 pp), -23.15% in FY2022 (+22.14 pp), -45.29% in FY2021 (+7.13 pp) and -52.42% in FY2020 (+4.68 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -57.85% in Q1 2023 to a high of -18.80% in Q2 2024 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last four quarters, with an average year-over-year change of +7.59 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2024, with a gain of 36.40 percentage points; the weakest was Q2 2025, with a drop of 22.15 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -40.95% (Q2 2025), -34.04% (Q1 2025) and -29.47% (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 17.83%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 17.92%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.28%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 19.32%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.54%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 16.66%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -5.97%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 11.86%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 20.76%
10 Dianthus Therapeutics 3.77 Bn 3.72 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -32.79%
Jun 30, 2025 -40.95%
Mar 31, 2025 -34.04%
Dec 31, 2024 -29.47%
Sep 30, 2024 -23.97%
Jun 30, 2024 -18.80%
Mar 31, 2024 -21.45%
Dec 31, 2023 -27.32%
Sep 30, 2023 -37.49%
Jun 30, 2023 -49.87%
Mar 31, 2023 -57.85%
Dec 31, 2022 -52.75%
Sep 30, 2022 -44.87%
Jun 30, 2022 -46.28%
Mar 31, 2022 -44.83%
Dec 31, 2021 -39.89%
Sep 30, 2021 -36.24%
Jun 30, 2021 -43.03%
Mar 31, 2021 -52.92%
Dec 31, 2020 -50.22%
API Access

Dianthus Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DNTH&period=max&api_key=YOUR_API_KEY